508 results on '"Townend, Jonathan N"'
Search Results
2. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
3. Post-donation Haemodynamic Consequences
4. Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction
5. Mineralocorticoid Receptor Antagonism in Heart Failure and Chronic Kidney Disease
6. Prevalence and Impact of Concomitant Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
7. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
8. A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation
9. Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction
10. Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
11. Mitral Regurgitation Following Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention—Prevalence, Risk factors, and Predictors of Outcome
12. Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome
13. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
14. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury
15. Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease
16. Acute kidney injury is more common in men than women after accounting for socioeconomic status, ethnicity, alcohol intake and smoking history
17. Comparison of Routine Versus Selective Glycoprotein IIb/IIIa Inhibitors Usage in Primary Percutaneous Coronary Intervention (from the British Cardiovascular Interventional Society)
18. Heart disease and stroke statistics 2023 update from the American Heart Association—implications for nephrology.
19. CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions
20. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors at 5 Years
21. Results of Serial Myocardial Perfusion Imaging in End-Stage Renal Disease
22. Dialysis Following Transcatheter Aortic Valve Replacement: Risk Factors and Outcomes: An Analysis From the UK TAVI (Transcatheter Aortic Valve Implantation) Registry
23. Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes
24. Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk factor?
25. Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines
26. Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal Disease
27. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
28. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury
29. Coronary Artery Calcium Assessment in CKD: Utility in Cardiovascular Disease Risk Assessment and Treatment?
30. Diffuse Interstitial Fibrosis and Myocardial Dysfunction in Early Chronic Kidney Disease
31. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
32. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
33. Effects of age and chronic kidney disease on regional aortic distensibility: A cardiovascular magnetic resonance study
34. Changing trends in the incidence, management and outcomes of coronary artery perforation over an 11-year period: single-centre experience
35. Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
36. A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
37. Percutaneous Mechanical Ventricular Support in Acute Cardiac Care: A UK Quaternary Centre Experience Using 2.5L, 3.8L and 5.0L Impella Catheters
38. Invite all donors to participate in follow-up studies
39. A Longitudinal Study of Mitral Regurgitation Detected after Acute Myocardial Infarction
40. Patient with Ischemic Heart Disease
41. Vascular stiffness in chronic kidney disease
42. Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?
43. The characteristics of mitral regurgitation: Data from patients admitted following acute myocardial infarction
44. Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease
45. Reducing Mortality In Myocardial Infarction: Treatment In Specialised Angioplasty Centres Should Follow Rapid Prehospital Thrombolysis
46. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors
47. Effect of Spironolactone on Left Ventricular Systolic and Diastolic Function in Patients With Early Stage Chronic Kidney Disease
48. Improving the diagnosis of heart failure in patients with atrial fibrillation
49. Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
50. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.